Global Drug Screening Market, By Product and Services (Equipment, Rapid Testing Devices (RTD), Consumables and Laboratory Services), Sample Type (Oral Fluid or Saliva, Breath, Hair and Other Samples), End User (Workplace and Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, and Pain Management Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The drug screening market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 17.35% in the forecast period of 2021 to 2028. The growing number of clinical trials will help in escalating the growth of the drug screening market. Drug screening test examines biological samples, for example blood, hair, and urine to detect the occurrence of drug abuse or its metabolites in patient’s body. Drug screening tests are utilized to establish if the person is or were under the effects of a drug at a certain point of time. Drug screening machines have enhanced due to the introduction of new technology, presenting the consumers accurate and correct results.
The increasing of the drug and alcohol ingesting, implementation of severe regulations authorizing drug and alcohol testing, controlling endorsements and product and facility promotions, growth in the alcohol ingesting amid youth as well as the ageing population, the misusing of the prescribed drugs, the upsurge in the usage of the narcotics and illegal drugs are the factors expected to boost the growth of the drug screening market in the forecast period.
However, the prohibition on the alcohol intake in several the countries, ban in the workplace drug testing in some countries are the factors most likely to further impede the growth of the drug screening market in the coming years. Additionally, the oral fluid testing, the fingerprint-based drug screening and the advancing countries extend profitable opportunities for the growth of the drug screening market in the near future. Despite that, the precision and the specificity issues regarding to the breathalysers further challenge the growth of the drug screening market during the forecast period.
This drug screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Drug Screening Market Scope and Market Size
The drug screening market is segmented on the basis of product and services, sample type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the product and services, the drug screening market is segmented into equipment, rapid testing devices (RTD), consumables and laboratory services. Equipment is further sub segmented into immunoassay analyzers, chromatography instruments, and breath analyzers. Breath analyzers is further sub segmented into semiconductor breath analyzers and fuel cell analyzers. Rapid testing devices (RTD) is further sub segmented into oral fluid testing devices and urine testing devices. Consumables is further sub segmented into assay kits, calibrators and controls, and sample collection cups.
- Based on the sample type, the drug screening market is segmented into oral fluid or saliva, breath, hair and other samples. Other samples is further sub segmented into blood AND sweat.
- Based on the end user, the drug screening market is segmented into workplace and schools, criminal justice systems and law enforcement agencies, drug testing laboratories, drug treatment centers, hospitals, personal users, and pain management centers.
Drug Screening Market Country Level Analysis
The drug screening market is analysed and market size insights and trends are provided by country, product and services, sample type and end user as referenced above.
The countries covered in the drug screening market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the drug screening market because of the increasing ingesting of illegal drugs, accessibility of government backing to control drug abuse, and the existence of rules encouraging drug screening, and the rising problem of chances because of insecure levels of alcohol ingesting. Asia Pacific anticipated observing significant amount of growth in the drug screening market because of the existence of top market players. Furthermore, the expansion in research and development services, accessible disposable income, and promptly creating economic circumstances.
The country section of the drug screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The drug screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for healthcare analytical testing services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug screening market. The data is available for historic period 2010-2019.
Competitive Landscape and Drug Screening Market Share Analysis
The drug screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug screening market.
The major players covered in the drug screening market report are Siemens Healthcare GmbH, Quest Diagnostics Incorporated, Alere, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Abbott, Hoffmann -La Roche Ltd, BioMerieux SA, Express Diagnostics Int’l, Inc., Drägerwerk AG & Co. KGaA, Bio-Rad Laboratories Inc., Biomedical Diagnostics, MPD, Inc., Danaher, Synergy Health plc., Agilent Technologies, Shimadzu Medical Pvt. Ltd., Laboratory Corporation of America Holdings, Alere Inc., OraSure Technologies, Alfa Scientific Designs Inc., Thermo Fisher Scientific, Drägerwerk AG & Co. KGaA,, LifeLoc Technologies, Inc., MPD Inc., Omega Laboratories, Inc., Premier Biotech, Inc., Psychemedics Corporation, Siemens Healthineers Private Limited, American Bio Medica Corporation, Sciteck, Inc., ACM Global Laboratories., CareHealth America, Clinical Reference Laboratory, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Drug Screening Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.